Boron therapy shows promise for tough brain tumors
Disease control
Completed
This completed phase I/II trial tested a treatment called boron neutron capture therapy (BNCT) using a boron-based drug (B10 L-BPA) in 10 adults with recurrent meningioma, a type of brain tumor. The goal was to see if the treatment is safe and can shrink tumors or stop them from …
Phase: PHASE1, PHASE2 • Sponsor: Heron Neutron Medical Corp. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC